Description: Cutera, Inc., a medical device company, engages in the research, design, development, manufacture, marketing, sale, and service of laser and other energy based aesthetics systems for practitioners worldwide. The company offers a range of non-invasive laser and intense pulsed light products for use in the treatment of cosmetic vascular conditions, hair removal, vascular lesions, skin rejuvenation, onychomycosis or toenail fungus, pigmented lesions, laser skin toning, tattoo removal, cutaneous lesions, fine wrinkles, diffuse redness, rosacea, skin texture, and pore size, as well as for non-invasive body contouring applications. It primarily serves plastic surgeons, dermatologists, gynecologists, primary care physicians, family practitioners, physicians offering aesthetic treatments in non-medical offices, podiatrists, and other qualified practitioners. The company sells and markets its products through its direct sales force and distributors, as well as sells hand piece refills through the Internet. Cutera, Inc. was founded in 1998 and is headquartered in Brisbane, California.
Home Page: www.cutera.com
CUTR Technical Analysis
3240 Bayshore Boulevard
Brisbane,
CA
94005
United States
Phone:
415 657 5500
Officers
| Name | Title |
|---|---|
| Mr. J. Daniel Plants | Exec. Chairman |
| Mr. David H. Mowry | CEO & Director |
| Mr. Rohan R. Seth | Chief Financial Officer |
| Dr. Michael A. Karavitis Ph.D. | Exec. VP & Chief Technology Officer |
| Mr. Charles G. Thier | Chief Information Officer |
| Anne Werdan | Director of Investor Relations |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 61.4772 |
| Price-to-Sales TTM: | 3.5986 |
| IPO Date: | 2004-03-31 |
| Fiscal Year End: | December |
| Full Time Employees: | 461 |